ABSTRACT
Objective@#To analyze the prognostic factors of adult nonclear cell renal cell carcinoma (nccRCC).@*Methods@#The clinical data of 286 patients with pathologically diagnosed one specific type of nccRCC after radical nephrectomy and nephron sparing surgery(NSS) in the affiliated hospital of Qingdao university followed up from January 2012 to January 2019 were retrospectively analyzed.There were 159 males and 127 females. Their age ranged from 17 to 81 years old, with an average age of 53. Based on the AJCC combination stage, 218 cases were in stage Ⅰ, 56 cases were in stage Ⅱ, 9 cases were in stage Ⅲ, 3 cases were in stage Ⅳ. Assay indicators were collected, including lymphocyte percentage(LY%)(31.5±10.5), neutrophil-lymphocyte ratio(NLR)(2.6±2.8), albumin(40.9±4.7)g/L, prealbumin(255.0±74.3)mg/L, lactate dehydrogenase (LDH)(201.0±174.0)U/L, creatine kinase isoenzyme (CK-MB)(20.0±62.1)U/L, total cholesterol(4.9±1.0)mmol/L, blood urea nitrogen/creatinine (BUN/Cr)(12.9±9.9), blood glucose(5.4±1.3)mmol/L, triglyceride(1.4±1.1)mmol/L, low-density lipoprotein cholesterol (LDL-C)(2.9±0.8)mmol/L. The optimal cut-off value of the above indexes were obtained by the receiver operating characteristic curve(ROC) in the SPSS software, and difference between high cut-off and low cut-off divided basing on the optimal cut-off value were evaluated respectively. The prognostic factors of adult nccRCC were evaluated by univariate and multivariate Cox proportional hazards regression analysis. Kaplan-Meier survival curve was used to study the survival relationship. The log-rank test were used to compare survival rate in two groups. The prognostic factors of nccRCC were analyzed after the results above were presented. Prognostic factors in renal chromophobe cell carcinoma and papillary cell carcinoma were analyzed by the same method.@*Results@#The 286patients were followed up from 1 to 87 months, with an average of 43.9 months. The 3-year and 5-year survival rates were 93.8% and 89.3%, respectively. Results of univariate and multivariate Cox regression model revealed that AJCC combined staging (HR=2.38, 95%CI1.48-3.83), LDH(HR=2.99, 95%CI1.16-7.69), blood glucose (HR=4.13, 95%CI 1.74-9.78), CK-MB (HR=3.85, 95%CI1.63-9.08) were independent prognostic factors of nccRCC. NLR(HR=8.28, 95%CI1.66-41.35) and LDH(HR=9.82, 95%CI2.94-32.82) were the independent prognostic factor in the renal chromophobe cell carcinoma subgroup and the papillary renal cell carcinoma subgroup, separately.@*Conclusions@#AJCC combination stage, LDH, blood glucose and CK-MB are independent prognostic factors of adult nccRCC. Patients with low LDH, hypoglycemia, CK-MB and early AJCC stage have better prognosis. NLR is an independent predictor of renal chromophobe cell carcinoma, and the low NLR group has a better prognosis and higher survival rate. LDH is an independent predictor of papillary renal cell carcinoma and low LDH is beneficial to patients' prognosis. NLR and LDH can be used as a prognostic indicator for clinical evaluation in renal chromophobe cell carcinoma and papillary renal cell carcinoma, respectively.
ABSTRACT
Objective To analyze the prognostic factors of adult nonclear cell renal cell carcinoma (nccRCC).Methods The clinical data of 286 patients with pathologically diagnosed one specific type of nccRCC after radical nephrectomy and nephron sparing surgery (NSS) in the affiliated hospital of Qingdao university followed up from January 2012 to January 2019 were retrospectively analyzed.There were 159 males and 127 females.Their age ranged from 17 to 81 years old,with an average age of 53.Based on the AJCC combination stage,218 cases were in stage Ⅰ,56 cases were in stage Ⅱ,9 cases were in stage Ⅲ,3 cases were in stage Ⅳ.Assay indicators were collected,including lymphocyte percentage(LY％) (31.5 ± 10.5),neutrophil-lymphocyte ratio(NLR) (2.6 ± 2.8),albumin (40.9 ± 4.7) g/L,prealbumin (255.0 ± 74.3) mg/L,lactate dehydrogenase (LDH) (201.0 ± 174.0) U/L,creatine kinase isoenzyme (CK-MB) (20.0 ± 62.1) U/L,total cholesterol (4.9 ± 1.0) mmol/L,blood urea nitrogen/creatinine (BUN/Cr) (12.9 ±9.9),blood glucose(5.4 t± 1.3) mmol/L,triglyceride (1.4 ± 1.1) mmol/L,low-density lipoprotein cholesterol (LDL-C) (2.9 ± 0.8) mmol/L.The optimal cut-off value of the above indexes were obtained by the receiver operating characteristic curve(ROC) in the SPSS software,and difference between high cut-off and low cut-off divided basing on the optimal cut-off value were evaluated respectively.The prognostic factors of adult nccRCC were evaluated by univariate and multivariate Cox proportional hazards regression analysis.Kaplan-Meier survival curve was used to study the survival relationship.The log-rank test were used to compare survival rate in two groups.The prognostic factors of nccRCC were analyzed after the results above were presented.Prognostic factors in renal chromophobe cell carcinoma and papillary cell carcinoma were analyzed by the same method.Results The 286patients were followed up from 1 to 87 months,with an average of 43.9 months.The 3-year and 5-year survival rates were 93.8％ and 89.3％,respectively.Results of univariate and multivariate Cox regression model revealed that AJCC combined staging (HR =2.38,95％ CI1.48-3.83),LDH (HR =2.99,95％ CI1.16-7.69),blood glucose (HR =4.13,95％ CI 1.74-9.78),CK-MB (HR =3.85,95％ CI1.63-9.08) were independent prognostic factors of nccRCC.NLR(HR =8.28,95％ CI1.66-41.35) and LDH (HR =9.82,95％ CI2.94-32.82) were the independent prognostic factor in the renal chromophobe cell carcinoma subgroup and the papillary renal cell carcinoma subgroup,separately.Conclusions AJCC combination stage,LDH,blood glucose and CK-MB are independent prognostic factors of adult nccRCC.Patients with low LDH,hypoglycemia,CK-MB and early AJCC stage have better prognosis.NLR is an independent predictor of renal chromophobe cell carcinoma,and the low NLR group has a better prognosis and higher survival rate.LDH is an independent predictor of papillary renal cell carcinoma and low LDH is beneficial to patients'prognosis.NLR and LDH can be used as a prognostic indicator for clinical evaluation in renal chromophobe cell carcinoma and papillary renal cell carcinoma,respectively.